True but this is by far the hardest thing for the company to do now that we know the drug is antiviral against dengue in humans and safe for phase 2b and 3 this can’t possibly be valued anywhere near what it was
True but this is by far the hardest thing for the company to do...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
-0.015(10.0%) |
Mkt cap ! $31.87M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 15.0¢ | 13.0¢ | $111.7K | 799.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 125000 | 2 |
View Market Depth
| Last trade - 15.30pm 19/06/2025 (20 minute delay) ? |
| ILA (ASX) Chart |